MOYES JAY M sold 57.4% of their position (22K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $76.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2023ACC: 0001437749-23-017610
+5K
Net shares
Net buyer
$76.0K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
27K acquired · 22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−22K
Price / share
$3.45
Trade value
$75.97K
% of position
57.4%
6/13/2023
38.32K→16.32K
Common Stock
Direct
Shares
+27K
Price / share
—
Trade value
—
% of position
165.4%
6/13/2023
16.32K→43.32K
Total
Net shares
+5K
Net value
-$75.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2023 | S · Sale | −22K | $3.45 | $75.97K | 57.4% | 38.32K | 16.32K |
| Common Stock Direct | 6/13/2023 | A · Award | +27K | — | — | 165.4% | 16.32K | 43.32K |
| Total | +5K | -$75.97K | ||||||
Derivative Transactions0
No derivative transactions reported